Skip to main content
Equibles
ACH logo

ACH · Accendra Health Inc/Va/ · Metrics

Track ACH — free

Use ACH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.26 0.00 (-0.16%)
Russell 2000 member Rebalance outlook locked
Market Cap
$18.00M
Shares
76.90M
Volume · Oct 21 43.19K Avg daily vol (3M) 1.68M

ACH metrics

90 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.26
Market cap
$18.00M

Price action

20 metrics
Price change (1W)
-43.6%
Price change (30D)
-74.7%
Price change (3M)
-93.4%
Price change (6M)
-93.7%
Price change (YTD)
-92.1%
Price change (1Y)
-95.4%
Trailing year
Price change (5Y)
-99.3%
52-week high
$5.51
52-week low
$0.22
Change from 52-week high
-96.0%
Change from 52-week low
+0.0%
Annualized volatility
104.0%
Annualized volatility (3M)
140.2%
Beta
1.0
RSI (14D)
11.0
Price vs SMA 50
-75.1%
Price vs SMA 200
-90.6%
Avg volume (3M)
1.62M
Relative volume
3.0
Average dollar volume
$1.74M

Company

3 metrics
Sector
Healthcare
Industry
Medical Distribution
Shares outstanding
76.90M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 153.3%
EV / EBITDA
6.1×
reciprocal yield 16.5%
EV / EBIT
58.8×
reciprocal yield 1.7%
P / sales
0.0×
reciprocal yield 15,951.1%
P / book
—
FCF yield
-2,152.3%
TTM · current market cap
Buyback yield
52.3%
P / FCF
—
P / operating cash flow
—
Earnings yield
-1,820.6%

Historical valuation

8 metrics
P / E historical average (3Y)
24.2×
reciprocal yield 4.1%
P / E historical average (5Y)
24.2×
reciprocal yield 4.1%
EV / revenue historical average (3Y)
0.4×
reciprocal yield 239.8%
EV / revenue historical average (5Y)
0.4×
reciprocal yield 237.4%
EV / EBIT historical average (3Y)
47.6×
reciprocal yield 2.1%
EV / EBIT historical average (5Y)
41.1×
reciprocal yield 2.4%
EV / EBITDA historical average (3Y)
19.3×
reciprocal yield 5.2%
EV / EBITDA historical average (5Y)
15.5×
reciprocal yield 6.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
—
Operating margin
1.1%
Trailing 12 months
Net margin
-11.4%
Gross profit (TTM)
$2.21B
Operating profit (TTM)
$29.35M
Net income (TTM)
−$302.14M
Trailing 12 months
Diluted EPS (TTM)
$-3.93
FCF margin
-13.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$34.55
Gross profit per diluted share (TTM)
$28.72
Operating profit per diluted share (TTM)
$0.38
EBITDA per diluted share (TTM)
$3.72
Net income per diluted share (TTM)
$-3.93
Operating cash flow per diluted share (TTM)
$-2.33
Free cash flow per diluted share (TTM)
$-4.63
Capital expenditures per diluted share (TTM)
$2.30
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-7.16

Growth

11 metrics
Revenue growth YoY
-10.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.65B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-34.8%
Revenue CAGR (5Y)
-20.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-14.3%
Debt / equity
—
Current ratio
0.4
EBITDA (TTM)
$285.43M
Free cash flow (TTM)
−$357.19M
Quick ratio
0.3
Interest coverage
0.2
Net debt / EBITDA
6.0
Return on invested capital
—
Trailing 12 months
Net cash
−$1.71B
Latest balance sheet
Cash & equivalents
$7.65M
Total assets
$2.11B
Total debt
$1.72B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$180.42M
Capital expenditures (TTM)
$176.77M
R&D (TTM)
—
SG&A (TTM)
$1.04B
Stock compensation (TTM)
$10.67M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
140
13F filer change QoQ
-4
Institutional ownership
82.9%
Conviction holders (share of 13F filers)
0.7%
Crowding (high-turnover and private-fund holders)
42.8%
Private-fund adviser ownership
37.4%
Active holders' share change QoQ
-1.0%
Holder tenure
12.8
Price vs estimated holder cost
-58.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
16.3%

Short interest

3 metrics
Short interest
11.0%
Latest settlement · 4.9 days to cover
Days to cover
4.9d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 75252 CUSIP 690732102 13F (30d) 22 filings 11 filers Visit website Investor relations